Alyssa Unell

Alejandro Lozano, Jeffrey Nirschl, James Burgess et al. · stanford

Recent advances in microscopy have enabled the rapid generation of terabytes of image data in cell biology and biomedical research. Vision-language models (VLMs) offer a promising solution for large-scale biological image analysis, enhancing researchers' efficiency, identifying new image biomarkers, and accelerating hypothesis generation and scientific discovery. However, there is a lack of standardized, diverse, and large-scale vision-language benchmarks to evaluate VLMs' perception and cognition capabilities in biological image understanding. To address this gap, we introduce μ-Bench, an expert-curated benchmark encompassing 22 biomedical tasks across various scientific disciplines (biology, pathology), microscopy modalities (electron, fluorescence, light), scales (subcellular, cellular, tissue), and organisms in both normal and abnormal states. We evaluate state-of-the-art biomedical, pathology, and general VLMs on μ-Bench and find that: i) current models struggle on all categories, even for basic tasks such as distinguishing microscopy modalities; ii) current specialist models fine-tuned on biomedical data often perform worse than generalist models; iii) fine-tuning in specific microscopy domains can cause catastrophic forgetting, eroding prior biomedical knowledge encoded in their base model. iv) weight interpolation between fine-tuned and pre-trained models offers one solution to forgetting and improves general performance across biomedical tasks. We release μ-Bench under a permissive license to accelerate the research and development of microscopy foundation models.

Asad Aali, Muhammad Ahmed Mohsin, Vasiliki Bikia et al.

As language models (LMs) are increasingly adopted across domains, high-quality benchmarking frameworks that accurately estimate performance are essential for guiding deployment decisions. While frameworks such as Holistic Evaluation of Language Models (HELM) enable broad evaluation across tasks, they often rely on fixed prompts that fail to generalize across LMs, yielding unrepresentative performance estimates. Unless we approximate each LM's ceiling (maximum achievable via changes to the prompt), we risk underestimating performance. Declarative prompting frameworks, such as DSPy, offer a scalable alternative to manual prompt engineering by crafting structured prompts that can be optimized per task. However, such frameworks have not been systematically evaluated across established benchmarks. We present a reproducible DSPy+HELM framework that introduces structured prompting methods which elicit reasoning, enabling more accurate LM benchmarking. Using four prompting methods, we evaluate four frontier LMs across seven benchmarks (general/medical domain) against existing HELM baseline scores. We find that without structured prompting: (i) HELM underestimates LM performance (by 4% average), (ii) performance estimates vary more across benchmarks ($+$2% standard deviation), (iii) performance gaps are misrepresented (leaderboard rankings flip on 3/7 benchmarks), and (iv) introducing chain-of-thought reduces LM sensitivity to prompt design (smaller $Δ$ across prompts). To our knowledge, this is the first benchmarking study to systematically integrate structured prompting into an established evaluation framework, demonstrating how scalable performance-ceiling approximation yields more robust, decision-useful benchmarks. We open-source (i) DSPy+HELM Integration (https://github.com/stanford-crfm/helm/pull/3893) and (ii) Prompt Optimization Pipeline (https://github.com/StanfordMIMI/dspy-helm).

Alyssa Unell, Noel C. F. Codella, Sam Preston et al.

The National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines for cancer treatment. Translating complex patient presentations into guideline-compliant treatment recommendations is time-intensive, requires specialized expertise, and is prone to error. Advances in large language model (LLM) capabilities promise to reduce the time required to generate treatment recommendations and improve accuracy. We present an LLM agent-based approach to automatically generate guideline-concordant treatment trajectories for patients with non-small cell lung cancer (NSCLC). Our contributions are threefold. First, we construct a novel longitudinal dataset of 121 cases of NSCLC patients that includes clinical encounters, diagnostic results, and medical histories, each expertly annotated with the corresponding NCCN guideline trajectories by board-certified oncologists. Second, we demonstrate that existing LLMs possess domain-specific knowledge that enables high-quality proxy benchmark generation for both model development and evaluation, achieving strong correlation (Spearman coefficient r=0.88, RMSE = 0.08) with expert-annotated benchmarks. Third, we develop a hybrid approach combining expensive human annotations with model consistency information to create both the agent framework that predicts the relevant guidelines for a patient, as well as a meta-classifier that verifies prediction accuracy with calibrated confidence scores for treatment recommendations (AUROC=0.800), a critical capability for communicating the accuracy of outputs, custom-tailoring tradeoffs in performance, and supporting regulatory compliance. This work establishes a framework for clinically viable LLM-based guideline adherence systems that balance accuracy, interpretability, and regulatory requirements while reducing annotation costs, providing a scalable pathway toward automated clinical decision support.